2026 PROGRAM

ANZBMS 2026 Program
ANZBMS 2026

Program

This program is preliminary and subject to change.
Opens your browser's print dialog — choose "Save as PDF" as the destination. In "More settings," turn off "Headers and footers" for a clean page.
Session Types General Session Keynote / Symposium Concurrent Session A Concurrent Session B Plenary / Award Session Poster Session Social / Evening Event Break / Registration
Talk Types Invited Speaker Oral Abstract Clinical Case
Registration Open
1:30 PM – 7:30 PM L5 Foyer 1 & 2
2:30 PM – 4:00 PM Room 401
ANZBMS President's Function (by invitation only)
4:00 PM – 5:00 PM Meeting Room 502
5:00 PM – 6:00 PM Meeting Room 503/504/505
Chair: Belinda Beck
For the motion: Shoshana Sztal-Mazer & Kirtan Ganda
Against the motion: Mark Bolland & Ian Reid
6:00 PM – 6:30 PM L5 Foyer 1 & 2
Fracture Site, Aging, and Multimorbidity Shape Post-Fracture Consequences: A Whole-of-Population Study
Thach Tran
Determinants and Trends of Bone Mineral Density in Transfusion-Dependent Thalassaemia: A Retrospective Single-Centre Cohort Analysis
Michael MB Bennett
Bone marrow adipocytes fuel myeloma: phenotype and lipid profiling in MGUS and multiple myeloma
Melissa D Cantley
Mapping the osteoclast methylome and investigating its role in osteoporosis
Benjamin H Mullin
Spermidine improves fast-twitch muscle histopathology and specific-force, with no impact on bone, in the mdx mouse model of Duchenne muscular dystrophy
Ahmed Al Saedi
Cortical and trabecular bone changes in men with haemophilia: findings from The Haemophilia Osteoporosis Registry (THOR)
Ayse Zengin
The association between low bone mineral density and osteoporosis with machine-learning abdominal aortic calcification in the UK Biobank Imaging study
Joshua R Lewis
Audit of a tertiary hospital fracture liaison service as part of the national fragility fracture network strengths and weakness
Virginia T Katsidzira
Trabecular bone loss caused by circadian rhythm disruption is partially reversible in mice
Eugenie Macfarlane
A Patient-Derived DYSF Microdeletion Model Reveals Muscular Degeneration and Implications for Muscle-Bone Health
Ying-Hung Lin
Welcome Function (Welcome to Country & Welcome Remarks)
6:30 PM – 7:30 PM L5 Foyer 1 & 2
7:30 PM – 10:00 PM
Registration Open
7:30 AM – 8:00 PM L5 Foyer 1 & 2
8:30 AM – 9:15 AM Meeting Room 503/504/505
Chairs: Brenda Ta & Jacqueline Center
Arrotex logo
8:30 AM
The New Anabolic Era: Optimising Sequencing, Cycling, and Exit Strategies
Bente Langdahl
Invited Speaker
9:15 AM – 10:15 AM Meeting Room 503/504/505
Chairs: Martha Blank & Mark Cooper
9:15 AM
Targeted GP alerts improve osteoporosis treatment after minimal trauma fracture: Outcomes of the INTERCEPT multicentre cluster randomised controlled trial
Mawson Wang
Oral Abstract
9:35 AM
High-dose estradiol restores vertebral micro-architecture and strength in an adolescent mouse model of male-to-female transition
Varun S Venkatesh
Oral Abstract
9:55 AM
Increased STAT3 (Signal Transducer and Activator of Transcription 3) or VEGF (Vascular Endothelial Growth Factor) signalling in the osteoblast lineage leads to greater cortical porosity in the adult skeleton
Natalie YY Koh
Oral Abstract
Morning Tea
10:15 AM – 10:45 AM L5 Foyer 1 & 2
10:45 AM – 12:45 PM Meeting Room 503/504/505
Chairs: Grahame Elder & Mary Louise Fac
10:45 AM
Patterns of osteoporosis treatment initiation following low-trauma fracture: an Australian population-based cohort study
Mike Lin
Oral Abstract
11:00 AM
Repurposing FDA-Approved Drugs Targeting OXR1 to Suppress Osteoclastogenesis and Prevent Bone Loss
Xiaojun X.C. Chen
Oral Abstract
11:15 AM
Paternal occupational and household exposures during pregnancy; is there an association with offspring adult bone health and body composition?
Mia Percival
Oral Abstract
11:30 AM
Preterm piglets as a translational large-animal model of osteopenia of prematurity
Kun-Di Lee
Oral Abstract
11:45 AM
Hypophosphataemia following parenteral iron and antiresorptives in clinical practice
Karen Van
Oral Abstract
12:00 PM
Using single-cell transcriptomics to identify gene regulatory networks involved in rare skeletal disorders
Nilabhra R. Das
Oral Abstract
12:15 PM
Rethinking long-term denosumab therapy: extending treatment intervals in low-risk patients
Brenda Ta
Oral Abstract
12:30 PM
Central dopaminergic lesion induces asymmetrical femoral deterioration that becomes bilateral with limited oestrogen production
Tahnee B C Thatcher
Oral Abstract
Lunch
12:45 PM – 2:00 PM L5 Foyer 1 & 2
1:00 PM – 2:00 PM Room 507 & 508
Concurrent Session A
2:00 PM – 3:30 PM Meeting Room 503/504/505
Chairs: Bente Langdahl & Shejil Kumar
2:00 PM
Bone Health 2026: Clinical Updates
Hanh Nguyen
Invited Speaker
2:30 PM
The BMD response to ONERO exercise is driven by load magnitude and the BMD response to bone medication is enhanced by ONERO
Belinda R Beck
Oral Abstract
2:42 PM
Chronic multisite pain is associated with an increased risk of incident fracture at all major sites: a prospective cohort study
Nikola Markovic
Oral Abstract
2:54 PM
Associations of osteoporosis and fracture with incident cardiovascular disease: A systematic review and meta-analysis
Joshua R Lewis
Oral Abstract
3:06 PM
Cortical and trabecular microarchitectural deterioration in women with prosthetic hip and knee joint replacement
Ali Ghasem-Zadeh
Oral Abstract
3:18 PM
Reimagining routine health information systems to detect fracture risk and osteoporosis: a policy brief prepared for the World Health Organisation (WHO)
Marc Sim
Oral Abstract
Concurrent Session B
2:00 PM – 3:30 PM Room 507 & 508
Chairs: Jianguo Tao & Paul Anderson
2:00 PM
Beyond Mechanics: Endocrine and Cellular Cross Talk Between Muscle and Bone
Itamar Levinger
Invited Speaker
2:30 PM
Plasma Membrane-Endoplasmic Reticulum Tethering Drives Mechanotransduction in Bone and Tendon Cells
Ziming Chen
Oral Abstract
2:42 PM
Older women deposit bone with less collagen cross-linking and glycosaminoglycan content than bone made by younger women
Mary Louise Fac
Oral Abstract
2:54 PM
Mfsd12 deficiency in mice causes bone loss and a multisystem lysosomal storage disorder
Jasreen Kular
Oral Abstract
3:06 PM
Anti-tuberculosis drug bedaquiline suppresses osteoclastogenesis and prevents bone loss by modulating glycolysis and histone lactylation
Lizhen Li
Oral Abstract
Afternoon Tea
3:30 PM – 4:00 PM L5 Foyer 1 & 2
4:00 PM – 5:15 PM Meeting Room 503/504/505
Chairs: Varun Venkatesh & Natalie Sims
4:00 PM
Cutting edge tools to study bone
Edwin Hawkins
Invited Speaker
4:30 PM
Genetic determinants of trabecular bone score and their relationships with bone mineral density and fragility fractures
John P Kemp
Oral Abstract
4:42 PM
Longitudinal change in 3D shaper analysis versus aDXA in patients receiving romosozumab
Angela Sheu
Oral Abstract
4:54 PM
A novel surgical membrane with integrated antimicrobial nanoparticles for bone regeneration
Dawn E Coates
Oral Abstract
6:30 PM – 10:00 PM Meeting Room 503/504/505
7:25 PM
Successful treatment of symptomatic hypercalcaemia in FHH Type 3 with cinacalcet
Jack AL Cooper
Clinical Case
7:50 PM
A Skeleton in the Genome: Digenic Inheritance Unmasking a Progeroid Bone Fragility Syndrome
Sarah C Brennan
Clinical Case
8:40 PM
A Cautionary Tale: The Unknowns of Denosumab in Active High-Turnover McCune-Albright Syndrome
Christopher Chan
Clinical Case
9:05 PM
A diagnostic dilemma: a case report of PTH-independent hypercalcaemia in pregnancy
Dhiraj Samarasinghe
Clinical Case
Registration Open
7:00 AM – 8:00 PM L5 Foyer 1 & 2
7:15 AM – 8:30 AM Meeting Room 503/504/505
8:30 AM – 9:15 AM Meeting Room 503/504/505
Chairs: Lynda Bonewald & Nikola Stokovic
8:30 AM
The Gut Microbiome and Aging Bone
Christopher Hernandez
Invited Speaker
9:15 AM – 10:15 AM Meeting Room 503/504/505
Chairs: Marc Sim & Kara Anderson
9:15 AM
Accelerating Large-Area Ultrastructural Imaging of Bone Tissues by Integrating SEM-BSE with Diffusion-Based Deep Learning
Qiongxiang Q.L. Lin
Oral Abstract
9:21 AM
Bisphosphonates, vitamin D and calcium supplements in association with blood pressure in men
Rishitha Panuganti
Oral Abstract
9:27 AM
Lactoferrin enhances flucloxacillin activity against Staphylococcus aureus biofilms in periprosthetic joint infections: from in vitro to a rat model
Yang Sun
Oral Abstract
9:33 AM
Differential sensitivity to Wnt-3a and Wnt-5a signaling in primary osteoblasts isolated from hip and knee joints of male and female patients with osteoarthritis
Leilei Xu
Oral Abstract
9:39 AM
Burosumab-associated musculoskeletal improvement in a PHEX-negative adult with X-linked hypophosphataemia after prolonged conventional therapy
Tomasz J Block
Oral Abstract
9:45 AM
Correction of genetic dwarfism (achondroplasia) using CRISPR base-editing
Julian Chu
Oral Abstract
9:51 AM
Investigating the link between osteocyte health and paraspeckle formation in mechanical stress
Dane Webster
Oral Abstract
9:57 AM
Quantification of bone loss, periosteal bone formation and histopathological changes to the bone matrix in a mouse implant-related infection model
Qi Sun
Oral Abstract
10:03 AM
Effects of Bisphosphonates on Bone Structural Mechanical Properties in Ovariectomized Non-Human Primates: A Systematic Review and Meta-Analysis
Anna Maria Markarian
Oral Abstract
Morning Tea
10:15 AM – 10:45 AM L5 Foyer 1 & 2
10:45 AM – 11:15 AM Meeting Room 503/504/505
Chairs: John Kemp & Emma Duncan
10:45 AM
Multi-omics integration reveals candidate determinants of bone mineral density and the role of AZIN1 in bone homeostasis
Jianguo Tao
Invited Speaker
11:15 AM – 11:45 AM Meeting Room 503/504/505
Chairs: John Kemp & Emma Duncan
11:15 AM
Osteogrow-D: A Personalized Regenerative Strategy for Diverse Skeletal Environments
Nikola Stokovic
Invited Speaker
11:45 AM – 12:45 PM L5 Foyer 1 & 2
Amgen logo
Bone quality deteriorates in elastase-induced emphysema mice
Manabu Tsukamoto
Trabecular bone loss caused by circadian rhythm disruption is partially reversible in mice
Eugenie Macfarlane
Effects of denosumab or romosozumab on vascular calcification in dialysis patients — a systematic review and meta-analysis
Dueanchonnee Sribenjalak
Clinical Observation on Pain Relief and Functional Recovery of Ankle Fracture Patients Based on Traditional Chinese Medicine Fumigation Therapy
Yan Fu
Bone Mineral Density Response to Romosozumab in Severe Osteoporosis Associated with Spinal Cord Injury
Sarah C Brennan
Failure of Antiresorptive Therapy in Severe Osteoporosis: Implications for Perioperative Bone Optimisation
Thomas Ulahannan
Serum bicarbonate concentration is associated with lower bone mineral density at the lumbar spine in men
Kara Anderson
Musculoskeletal decline, intrinsic capacity and all-cause mortality for men in the Geelong Osteoporosis Study
Julie A Pasco
Bilateral spontaneous atypical femoral fractures: a highly morbid presentation of adult hypophosphatasia after delayed diagnosis
Erin Paul
When bone meets blindness: a case of osteoporosis-pseudoglioma syndrome complicated by atypical femur fracture
Jennifer Ngan
Breaking Convention: A Case Report of a Possible Atypical Ulna Fracture
Alec Ronan
Lunch
12:45 PM – 2:00 PM L5 Foyer 1 & 2
Concurrent Session A
2:00 PM – 3:30 PM Meeting Room 503/504/505
Chairs: Mawson Wang & Jasna Aleksova
2:00 PM
From Weight Loss to Bone Loss? Understanding Bone Health in the Obesity Drug Era
Angela Sheu
Invited Speaker
2:30 PM
Powerful engine, fragile chassis: lower bone mineral density in elite male cyclists despite high aerobic fitness
Ayse Zengin
Oral Abstract
2:42 PM
Body composition indices, physical function, and risk of fall and fracture in middle-aged adults: the Busselton Healthy Ageing Study
Kun Zhu
Oral Abstract
2:54 PM
Improved Body Composition, Gait Speed, and Personal Care in Older Adults in Aged Care: The Pomerium Study Trial, a 3-Month Multi-Nutrient Supplementation Randomised Controlled Trial
Ahmed Al Saedi
Oral Abstract
3:06 PM
Associations between modifiable lifestyle factors and incident fracture over ten years of follow-up: a preliminary phase for developing a fracture risk tool for the lay community
Kara B Anderson
Oral Abstract
3:18 PM
Higher skeletal muscle mass predicts reduced minimal trauma fracture and greater bone mineral density in Australian post-menopausal women
David M Medveczky
Oral Abstract
Concurrent Session B
2:00 PM – 3:30 PM Room 507 & 508
Chairs: Christopher Hernandez & Kaitlyn Flynn
2:00 PM
A decade of discovery: epigenetic control of mesenchymal stem cell fate links bone ageing, osteoporosis, and metabolic disease
Dimitrios D.C Cakouros
Invited Speaker
2:30 PM
ACC1-mediated mitochondrial fatty acid synthesis (mtFAS) governs osteoclast activation and bone loss
Zhongxiang Wang
Oral Abstract
2:42 PM
EphrinB2:EphB4 signalling limits lysosome formation in osteoblasts: in its absence lysosomes and collagen are released and promote mineralisation
Martha Blank
Oral Abstract
2:54 PM
Endogenous glucocorticoids induce neurogenic heterotopic ossification via mesenchymal and myeloid cells
Kylie A Alexander
Oral Abstract
3:06 PM
SOST-targeted Antisense Oligonucleotide Mimics Splicing Mutation in Sclerosteosis to Enhance Osteogenesis In Vitro
Jun Yuan
Oral Abstract
3:18 PM
Hyperbranched Polyglycerol-Coated Titanium Implants Reduce In Vivo Bacterial Burden Without Compromising Osseointegration
Paul H Anderson
Oral Abstract
3:30 PM – 4:30 PM L5 Foyer 1 & 2
Amgen logo
A Patient-Derived DYSF Microdeletion Model Reveals Muscular Degeneration and Implications for Muscle–Bone Health
Ying-Hung Lin
Targeting EFEMP1 Enhances Chondrogenesis and Inhibits Hypertrophic Differentiation in a Spontaneous Osteoarthritis Mouse Model
Mei-Feng Chen
Role of Membrane-Bound Phosphatase in the Balance Between Osteoclastogenesis and Adipogenesis Under Local Phosphorus Environment
Keito Matsubayashi
The association between emotional and behavioural problems and bone health: Is there a link in childhood?
Natalie Hyde
Elevated fracture risk in women with bipolar disorder
Kara B Anderson
REMS derived bone mineral density (BMD) variability observed across age and BMI segments from a large Australian patient cohort
Sherif Youssef
A Familial Cluster of Atypical Femoral Fractures Suggesting a Heritable Syndrome
Anushka Sharma
When Bone Breaks Under Pressure: Severe Osteoporosis and Hypercalcaemia in Prolonged Critical Illness — A Therapeutic Dilemma
Yi Shan Der
When survival outpaces evidence: bone health management in adults with Duchenne muscular dystrophy
Brenda Ta
Atypical parathyroid adenoma presenting with severe PTH-dependent hypercalcaemia
Aishah Virk
Afternoon Tea
3:30 PM – 4:00 PM L5 Foyer 1 & 2
6:00 PM – 7:00 PM Meeting Room 503/504/505
7:00 PM – 11:00 PM Meeting Room 503/504/505
Registration Open
8:00 AM – 1:30 PM L5 Foyer 1 & 2
8:30 AM – 10:00 AM Meeting Room 503/504/505
Chairs: Ayse Zengin & Joshua Lewis
Lived Experience, Co-design and Better Healthcare
Lisa Blake
Invited Speaker
Co-designing a digital health tool to support self-management of hypophosphatasia
Jack Dalla Via
Invited Speaker
Morning Tea
10:00 AM – 10:30 AM L5 Foyer 1 & 2
10:30 AM – 11:15 AM Meeting Room 503/504/505
Chairs: Michael Thompson & Marion Mundt
10:30 AM
Regenerative medicine for bone and joint diseases
Jiao Jiao Li
Invited Speaker
11:00 AM
Identifying Tendon, Ligament and Cartilage Stem Cells
Eugenie Macfarlane
Invited Speaker
11:15 AM – 11:45 AM Meeting Room 503/504/505
Chairs: Edwin Hawkins & Shoshana Sztal-Mazer
11:15 AM
Skeletal Fragility After Cancer Therapy
Frances Milat
Invited Speaker
11:45 AM – 12:45 PM Meeting Room 503/504/505
Chairs: Kirtan Ganda & Lisa Ward
11:45 AM
From Pixels to Patients: Digital Innovations in Bone Health
Marion Mundt
Invited Speaker
12:15 PM
A Novel Deep Learning Application to Predict High-risk Fracture Patients for Imminent Non-Fracture Re-Hospitalisations
Thach Tran
Oral Abstract
12:27 PM
Clinically Interpretable Predictors of Imminent Subsequent Fractures in a Deep-Learning Prediction Model
Huy Nguyen
Oral Abstract
12:45 PM – 1:00 PM Meeting Room 503/504/505
This program is preliminary and subject to change. All times are NZST.